Thoracic or lung cancer refers to malignant tumors that develop in the lungs or surrounding structures of the chest cavity, including the bronchi, trachea, and chest wall. Cancer Specialist in Ashok Vihar can provide expert care and treatment for those diagnosed with lung cancer. It is one of the most common types of cancer worldwide and a leading cause of cancer-related deaths. Lung cancer can be broadly categorized into two main types: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), each with distinct characteristics and treatment approaches.
Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases and includes several subtypes, such as adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. NSCLC tends to grow and spread more slowly than SCLC and may be treated with surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, or a combination of these treatments, depending on the stage and molecular characteristics of the cancer.
Small cell lung cancer (SCLC) is less common, accounting for about 15% of lung cancer cases, but it is typically more aggressive and fast-growing than NSCLC. SCLC is often treated with chemotherapy and radiation therapy, as well as immunotherapy in some cases. Surgery is less commonly used in the treatment of SCLC due to its tendency to spread quickly to other parts of the body.
The treatment approach for thoracic or lung cancer depends on several factors, including the type and stage of cancer, the patient’s overall health and treatment goals, and the presence of specific molecular markers or mutations that may influence treatment decisions. Treatment may involve a combination of surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, or palliative care to relieve symptoms and improve quality of life.
In recent years, advances in cancer research and treatment have led to the development of targeted therapies and immunotherapies that specifically target cancer cells or harness the body’s immune system to fight cancer. These treatments offer new options for patients with advanced or metastatic lung cancer and have led to improved outcomes and survival rates for many individuals.
Overall, thoracic or lung cancer remains a significant health challenge, but advances in early detection, diagnosis, and treatment have contributed to improved outcomes and quality of life for patients diagnosed with this disease. Early detection through screening programs and awareness of risk factors such as smoking can help reduce the burden of lung cancer and improve survival rates in affected individuals.
